Product Information

PAROXETINE HCL 40 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0983 per EA under NDC 62135054490. Its NADAC has been published 154 times since Sep 13, 2023.

FDA first approved this application on Nov 2, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PAROXETINE HCL 40 MG TABLET

PAROXETINE
$0.0983per EA

Strength

40 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135054490

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA211248

FDA Approved

11/2/2021

TE Code

AB

On Market Since

11/2/2021

Pharmacological Classes

Serotonin Reuptake Inhibitor
Serotonin Uptake Inhibitors

Price Statistics

The NADAC for PAROXETINE HCL 40 MG TABLET has been published 154 times since Sep 13, 2023, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0983 per EA
All-time high$0.1313 (Mar 13, 2024)
All-time low$0.0864 (Nov 20, 2024)
52-week high$0.1131
52-week low$0.0983
Median price$0.1099
Average price$0.1120
Largest weekly change+30.0% (Aug 21, 2024)
Weeks tracked154
Tracking sinceSep 13, 2023

Price History

1W

-1.7%

1M

-1.7%

3M

-10.0%

6M

-9.6%

1Y

-9.8%

3Y

N/A

5Y

N/A

All

-21.7%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PAROXETINE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PAROXETINE HCL 40 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PAROXETINE HCL 40 MG TABLET, manufactured by Chartwell RX LLC, is $0.0983 per EA (NDC 62135054490), effective Aug 19, 2026.

How has the price of PAROXETINE HCL 40 MG TABLET changed over time?

Over the history we have for it, the NADAC for PAROXETINE HCL 40 MG TABLET has declined 21.7%. It has been tracked across 154 weekly CMS publications since Sep 13, 2023.

What are the highest and lowest recorded NADAC prices for PAROXETINE HCL 40 MG TABLET?

Since Sep 13, 2023, the NADAC for PAROXETINE HCL 40 MG TABLET has ranged from a low of $0.0864 (Nov 20, 2024) to a high of $0.1313 (Mar 13, 2024), with a median of $0.1099 per EA.

Are there cheaper alternatives to PAROXETINE HCL 40 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PAROXETINE HCL 40 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PAROXETINE HCL 40 MG TABLET?

PAROXETINE HCL 40 MG TABLET (NDC 62135054490) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.